GigaGen
is a biotechnology company that develops and commercializes single-cell technology-based antibody drugs to treat infectious diseases... Read moreGigaGen
is a biotechnology company that develops and commercializes single-cell technology-based antibody drugs to treat infectious diseases... Read more
News
Nov 20, 2024
Clinical Trials Arena
GigaGen: GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment
Oct 07, 2024
Pharmabiz
GigaGen: GigaGen awarded US BARDA contract valued upto $135.2 mn to develop recombinant polyclonal antibody therapies for BoNT and an additional biothreat
Oct 03, 2024
The Business Journals: San Francisco Business Times
GigaGen: Peninsula biotech reels in potential $135 million contract to be first line of treatment against bioterrorism
May 21, 2024
Clinical Trials Arena
GigaGen: GigaGen doses first subject in Phase I advanced solid tumour trial
Dec 12, 2023
StreetInsider
Press Release: GigaGen : GigaGen Receives FDA Clearance of IND to Begin Phase 1 Trial of Oncology Drug Candidate, GIGA-564, in Solid Tumors
Nov 06, 2023
GlobalNewswire
Press Release: GigaGen : GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023
Oct 19, 2023
GlobeNewswire
Press Release: GigaGen : GigaGen Granted Expansion of Contract with US Department of Defense to Develop Synthetic Human Antibody Treatments for Botulinum Neurotoxins
Sep 28, 2023
GlobalNewswire
Press Release: GigaGen : GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564
Nov 01, 2022
StreetInsider
Press Release: GigaGen : ProteoNic announces broadening of GigaGen's rights to 2G UNic Technology
Sep 15, 2022
StreetInsider
Press Release: GigaGen : GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens
GigaGen Competitors
1
2
3
4
5
6
7
8
9
10